Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.

Davide BimbattiFrancesco PierantoniEleonora LaiMelissa BallestrinNicolò CavasinElisa ErbettaChiara De ToniUmberto Basso Maruzzo Marco

Published in: Cancers (2023)

Our retrospective real-life cohort of advanced nccRCC patients shows that immunotherapy-based combinations could improve ORR, PFS and OS compared to TKI monotherapy. Prospective trials for nccRCC patients utilizing novel therapies are ongoing and their results eagerly awaited.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
tyrosine kinase
advanced non small cell lung cancer